{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:48:44Z","timestamp":1787010524591,"version":"build-2736575974"},"reference-count":49,"publisher":"Microbiology Society","issue":"7","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1149991"],"award-info":[{"award-number":["1149991"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,20]]},"abstract":"<jats:p>\n                    <jats:italic>\n                      <jats:named-content content-type=\"species\">\n                        <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/doi.org\/10.1601\/nm.5677\" xlink:type=\"simple\">Streptococcus pneumoniae<\/jats:ext-link>\n                      <\/jats:named-content>\n                    <\/jats:italic>\n                    is a major human pathogen and can cause a range of conditions from asymptomatic colonization to invasive pneumococcal disease (IPD). The epidemiology and distribution of IPD-causing serotypes in Australia has undergone large changes following the introduction of the 7-valent pneumococcal conjugate vaccine (PCV) in 2005 and the 13-valent PCV in 2011. In this study, to provide a contemporary understanding of the IPD causing population in Victoria, Australia, we aimed to examine the population structure and prevalence of antimicrobial resistance using whole-genome sequencing and comprehensive antimicrobial susceptibility data of 1288 isolates collected between 2018 and 2022. We observed high diversity among the isolates with 52 serotypes, 203 sequence types (STs) and 70 Global Pneumococcal Sequencing Project Clusters (GPSCs) identified. Serotypes contained in the 13v-PCV represented 35.3\u200a% (\n                    <jats:italic>n<\/jats:italic>\n                    =405) of isolates. Antimicrobial resistance (AMR) to at least one antibiotic was identified in 23.8\u200a% (\n                    <jats:italic>n<\/jats:italic>\n                    =358) of isolates with penicillin resistance the most prevalent (20.3\u200a%,\n                    <jats:italic>n<\/jats:italic>\n                    =261 using meningitis breakpoints and 5.1\u200a%\n                    <jats:italic>n<\/jats:italic>\n                    =65 using oral breakpoints). Of the AMR isolates, 28\u200a% (\n                    <jats:italic>n<\/jats:italic>\n                    =101) were multidrug resistant (MDR) (resistant to three or more drug classes). Vaccination status of cases was determined for a subset of isolates with 34 cases classified as vaccine failure events (fully vaccinated IPD cases of vaccine serotype). However, no phylogenetic association with failure events was observed. Within the highly diverse IPD population, we identified six high-risk sub-populations of public health concern characterized by high prevalence, high rates of AMR and MDR, or serotype inclusion in vaccines. High-risk serotypes included serotypes 3, 19F, 19A, 14, 11A, 15A and serofamily 23. In addition, we present our data validating seroBA for\n                    <jats:italic>in silico<\/jats:italic>\n                    serotyping to facilitate ISO-accreditation of this test in routine use in a public health reference laboratory and have made this data set available. This study provides insights into the population dynamics, highlights non-vaccine serotypes of concern that are highly resistant, and provides a genomic framework for the ongoing surveillance of IPD in Australia which can inform next-generation IPD prevention strategies.\n                  <\/jats:p>","DOI":"10.1099\/mgen.0.001070","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T12:16:54Z","timestamp":1689855414000},"source":"Crossref","is-referenced-by-count":12,"title":["Population structure, serotype distribution and antibiotic resistance of Streptococcus pneumoniae causing invasive disease in Victoria, Australia"],"prefix":"10.1099","volume":"9","author":[{"given":"Charlie","family":"Higgs","sequence":"first","affiliation":[{"name":"Department of Microbiology & Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamali Sadeesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerrie","family":"Stevens","sequence":"additional","affiliation":[{"name":"Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Strachan","sequence":"additional","affiliation":[{"name":"Department of Health, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norelle L.","family":"Sherry","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"},{"name":"Department of Microbiology & Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy","family":"Horan","sequence":"additional","affiliation":[{"name":"Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Zhang","sequence":"additional","affiliation":[{"name":"Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Stinear","sequence":"additional","affiliation":[{"name":"Centre for Pathogen Genomics, University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Department of Microbiology & Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0237-1473","authenticated-orcid":false,"given":"Benjamin P.","family":"Howden","sequence":"additional","affiliation":[{"name":"Department of Microbiology & Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"},{"name":"Centre for Pathogen Genomics, University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"},{"name":"Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire L.","family":"Gorrie","sequence":"additional","affiliation":[{"name":"Centre for Pathogen Genomics, University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"},{"name":"Department of Microbiology & Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0001-8"},{"key":"R2","article-title":"Global Pneumococcal Disease and Vaccination | CDC","year":"2022"},{"key":"R3","article-title":"Pneumonia"},{"key":"R4","first-page":"E267","article-title":"Enhanced invasive Pneumococcal disease surveillance working group for the communicable diseases network Australia. invasive Pneumococcal disease in Australia, 2011 and 2012","author":"Toms","year":"2016","journal-title":"Commun Dis Intell Q Rep"},{"key":"R5","first-page":"373","article-title":"23-Valent Pneumococcal polysaccharide vaccine. WHO position paper","volume":"83","year":"2008","journal-title":"Releve Epidemiol Hebd"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2019.08.007"},{"key":"R7","first-page":"E151","article-title":"Invasive Pneumococcal disease in Australia 2007 and 2008","volume":"36","author":"Barry","year":"2012","journal-title":"Commun Dis Intell Q Rep"},{"key":"R8","article-title":"The Australian Immunisation Handbook","year":"2018"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.33321\/cdi.2019.43.51"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.10.008"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1093\/gbe\/evu120"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2625"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030168"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005095"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(67)92346-X"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1996.tb101349.x"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.10.098"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1086\/381197"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.02.038"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.04.021"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000204"},{"key":"R22","article-title":"Snapshot of Australia, 2021 | Australian Bureau of Statistics","year":"2022"},{"key":"R23","article-title":"Communicable Diseases Network Australia. Invasive pneumococcal disease: Australian national notifiable diseases case definition","year":"2004"},{"key":"R24","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing, M100. 31st ed","year":"2022"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1540-z"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.3791\/51208"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.14826.1"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1101\/gr.241455.118"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35713-4"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91456-0"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msu300"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq706"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1111\/2041-210X.12628"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.21105\/joss.01686"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btx364"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35270-1"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad067"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30297-X"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.3390\/genes10090687"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007438"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00591-15"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000090"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1093\/gbe\/evx092"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000998"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.05.075"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2018.08.004"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.06.041"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000851"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01370-21"}],"container-title":["Microbial Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/mgen\/10.1099\/mgen.0.001070?crawler=true&mimetype=application\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T12:17:00Z","timestamp":1689855420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/mgen\/10.1099\/mgen.0.001070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,20]]}},"URL":"https:\/\/doi.org\/10.1099\/mgen.0.001070","relation":{},"ISSN":["2057-5858"],"issn-type":[{"value":"2057-5858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]}}}